Nirmatrelvir-ritonavir reduced the risk for long COVID in adults aged 50 years and older but not in adolescents.
Interferon-α nasal spray was safe and effective in reducing COVID-19 risk by 40% in patients with cancer, demonstrating its potential as an additional preventive strategy alongside vaccines and ...
EXCLUSIVE: Tongal, the creators’ platform, is launching an animated series inspired by artwork from a patient at St. Jude ...
A widely available and affordable drug has been shown to be effective in treating seriously ill COVID-19 patients, according ...
A widely available and affordable drug has been shown to be effective in treating seriously ill COVID-19 patients, according to a new international study led by researchers at the Australian National ...
Researchers have developed a new lipid for delivering mRNA that is safer and more effective than current technologies. By ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback